PASSANISI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 3.332
NA - Nord America 2.150
AS - Asia 1.862
SA - Sud America 544
AF - Africa 56
OC - Oceania 5
Totale 7.949
Nazione #
US - Stati Uniti d'America 2.065
RU - Federazione Russa 1.912
SG - Singapore 796
BR - Brasile 458
CN - Cina 428
IT - Italia 408
IE - Irlanda 307
HK - Hong Kong 226
SE - Svezia 215
VN - Vietnam 129
DE - Germania 112
PL - Polonia 76
FR - Francia 73
IN - India 72
GB - Regno Unito 59
CA - Canada 43
AT - Austria 42
BD - Bangladesh 42
FI - Finlandia 38
TH - Thailandia 36
MX - Messico 32
AR - Argentina 30
ID - Indonesia 30
JP - Giappone 18
ZA - Sudafrica 18
ES - Italia 16
EC - Ecuador 15
IQ - Iraq 14
VE - Venezuela 14
BE - Belgio 13
NL - Olanda 13
PK - Pakistan 13
TR - Turchia 12
CO - Colombia 10
MA - Marocco 9
TN - Tunisia 8
CL - Cile 7
UA - Ucraina 7
EG - Egitto 6
SI - Slovenia 6
DZ - Algeria 5
KE - Kenya 5
PH - Filippine 5
UY - Uruguay 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
PA - Panama 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BO - Bolivia 3
GR - Grecia 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
AL - Albania 2
BG - Bulgaria 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KR - Corea 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
HR - Croazia 1
IS - Islanda 1
JE - Jersey 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
SC - Seychelles 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 7.949
Città #
Ashburn 547
Moscow 547
Singapore 438
Dublin 306
Hong Kong 224
Dallas 208
Chandler 194
Messina 185
Nyköping 129
San Jose 127
Beijing 108
Los Angeles 75
Warsaw 67
The Dalles 66
Council Bluffs 52
Munich 45
São Paulo 42
Ho Chi Minh City 41
Lauterbourg 40
Bangkok 35
Catania 34
Medford 34
Princeton 34
Buffalo 31
New York 31
Frankfurt am Main 27
Vienna 27
Santa Clara 25
Tianjin 24
Hanoi 23
Guangzhou 22
Redondo Beach 22
Shenzhen 21
Jakarta 19
Pune 18
Tokyo 18
Nuremberg 17
Brooklyn 16
Montreal 14
Brussels 13
Dearborn 13
Des Moines 13
Helsinki 13
London 12
Mexico City 12
Orem 12
Turku 12
Belo Horizonte 11
Qingdao 11
Brasília 10
Seattle 10
Toronto 10
Da Nang 9
Jacksonville 9
Johannesburg 9
Lappeenranta 9
Rome 9
Wilmington 9
Amsterdam 8
Atlanta 8
Baghdad 8
Chicago 8
Curitiba 8
Düsseldorf 8
Hyderabad 8
Manchester 8
Porto Alegre 8
Viagrande 8
Chennai 7
Milan 7
Palermo 7
Quito 7
Shanghai 7
Boardman 6
Boston 6
Cairo 6
Caracas 6
Guarulhos 6
New Delhi 6
Phoenix 6
Rio de Janeiro 6
San Benedetto del Tronto 6
San Francisco 6
Shenyang 6
Stockholm 6
Zhengzhou 6
Campo Grande 5
Dhaka 5
Houston 5
Maribor 5
Nairobi 5
Nanjing 5
Poplar 5
Roubaix 5
Santiago 5
Tunis 5
Wroclaw 5
Agadir 4
Baku 4
Bari 4
Totale 4.399
Nome #
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue 246
Allergic contact dermatitis and diabetes medical devices: 2 clinical cases 214
Direct Drug Provocation Test for the Diagnosis of Self-Reported, Mild and Immediate Drug Hypersensitivity Reaction in Children and Adolescents: Our Real-Life Experience 182
Are Children Most of the Submerged Part of SARS-CoV-2 Iceberg? 177
Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation 174
A rare cause of pediatric hypoglycemia in a boy: a malignat insulinoma 174
An Innovative Advanced Hybrid Closed-Loop System for Glucose Control in Children and Adolescents with Type 1 Diabetes: A One-Year Real-World Study 162
Clinical and genetic features of maturity-onset diabetes of the young in pediatric patients: a 12-year monocentric experience 162
Clinical features in a patient with Turner syndrome and pericentric inversion of chromosome 9 162
Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019-2021 152
Phenotypic expression of Hashimoto's thyroiditis is absolutely atypical in girls with Turner syndrome 150
Omalizumab in children and adolescents with chronic spontaneous urticaria: Case series and review of the literature 148
One-Year Real-World Study on Comparison among Different Continuous Subcutaneous Insulin Infusion Devices for the Management of Pediatric Patients with Type 1 Diabetes: The Supremacy of Hybrid Closed-Loop Systems 145
Renal anomalies in newborns with vacterel association: case series and literature review 145
Quarantine Due to the COVID-19 Pandemic From the Perspective of Pediatric Patients With Type 1 Diabetes: A Web-Based Survey 144
Clinical Peculiarities in a Cohort of Patients with Wolfram Syndrome 1 144
High Prevalence of Skin Reactions among Pediatric Patients with Type 1 Diabetes Using New Technologies: The Alarming Role of Colophonium 143
Influence of age on partial clinical remission among children with newly diagnosed type 1 diabetes 140
GCK-MODY in a child with cystic fibrosis: The doubt of the treatment plan 139
Vulvar contact dermatitis caused by sensitization to colophonium in a patient with type 1 diabetes 138
Quarantine due to the COVID-19 pandemic from the perspective of adolescents: the crucial role of technology 136
Prevalence and clinical features of severe diabetic ketoacidosis treated in pediatric intensive care unit: a 5-year monocentric experience 135
Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a New Continuous Glucose Monitoring Metric in Children and Adolescents with Type 1 Diabetes Using Different Treatment Modalities 133
Vaccinations and Immune Response in Celiac Disease 131
Has COVID-19 lockdown improved glycaemic control in pediatric patients with type 1 diabetes? An analysis of continuous glucose monitoring metrics 131
Biologics in food allergy: up-to-date 124
Congenital portosystemic shunt: our experience 123
Association between osteocalcin and residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes: a pivotal study 123
Vitulia questionnaire: a new instrument to evaluate quality of life in children aged 4-7 years with food allergy 121
Long term treatment with omalizumab in adolescent with refractory solar urticaria 119
MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control 113
Vitamin B12 deficiency in type 1 diabetes patient with thalassemia trait: the challenge of early diagnosis 112
Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study 112
Device-Related Skin Reactions Increase Emotional Burden in Youths With Type 1 Diabetes and Their Parents 106
High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey 104
The evolution of allergen-specific immunotherapy: The near and far future 104
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease 104
Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED) 99
Hepatomegaly and type 1 diabetes: A clinical case of Mauriac's syndrome 97
Time in tight range in automated insulin delivery system users: Real‐world data from children and adolescents with type 1 diabetes 96
Gastroparesis in Adolescent Patient with Type 1 Diabetes: Severe Presentation of a Rare Pediatric Complication 95
Anaphylaxis during OIT and its impact on treatment adherence: A retrospective study 90
Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia 89
Scurvy may occur even in children with no underlying risk factors: A case report 89
Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes: Ongoing Challenges in Care 88
Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation 87
Long-term use of Minimed™ 780G in children and adolescents with type 1 diabetes under real-world conditions: The benefits of optimal settings 87
Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study 84
Pathophysiology of Congenital High Production of IgE and Its Consequences: A Narrative Review Uncovering a Neglected Setting of Disorders 83
Skin Involvement in Paediatric Patients with Type 1 Diabetes 82
Use of teplizumab in children and adolescents at risk of type 1 diabetes: perspectives of parents and caregivers from an Italian Pediatric Diabetes Center 82
Sustained Effectiveness of an Advanced Hybrid Closed-Loop System in a Cohort of Children and Adolescents With Type 1 Diabetes: A 1-Year Real-World Study 82
Novel diagnostic techniques and therapeutic strategies for IgE-mediated food allergy 82
Exploring the Continuous Glucose Monitoring in Pediatric Diabetes: Current Practices, Innovative Metrics, and Future Implications 81
Technologies for Type 1 Diabetes and Contact Dermatitis: Therapeutic Tools and Clinical Outcomes in a Cohort of Pediatric Patients 76
Clinical relevance of short-term glycemic variability in children and adolescents with type 1 diabetes: a narrative review 76
Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study 74
Treatment of transient neonatal diabetes mellitus: Insulin pump or insulin glargine? Our experience 72
First International Survey on Diabetes Providers’ Assessment of Skin Reactions in Youth With Type 1 Diabetes Using Technological Devices 70
Vocal fold paralysis: A rare complication of measles encephalitis 69
The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes 69
Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review 66
Examining the associations between COVID-19 infection and pediatric type 1 diabetes 64
Glycemic Variability and Time in Range Are Associated with the Risk of Overweight and High LDL-Cholesterol in Children and Youths with Type 1 Diabetes 62
A retrospective analysis of 24‐month real‐world glucose control for children and adolescents with type 1 diabetes using the MiniMed™ 670G insulin pump 61
Real-World Performance of First- Versus Second-Generation Automated Insulin Delivery Systems on a Pediatric Population With Type 1 Diabetes: A One-Year Observational Study 57
Recurrent hypoglycaemia in type-1 diabetes mellitus may unravel the association with Addison's disease: A case report 55
Impact of Automated Insulin Delivery Systems in Children and Adolescents with Type 1 Diabetes Previously Treated with Multiple Daily Injections: A Single-Center Real-World Study 53
Prehypertension in adolescents with cardiovascular risk: A comparison between type 1 diabetic patients and overweight subjects 53
The interplay between psychological well-being, diabetes-related distress, and glycemic control: A continuous glucose monitoring analysis from a population of adolescents with type 1 diabetes 50
Reply to Foster, T.P.; Schatz, D. Comment on "Lombardo et al. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. Children 2022, 9, 1087" 48
Future acceptance of automated insulin delivery systems in youths with type 1 diabetes: validation of the Italian artificial pancreas-acceptance measure 34
Evaluation of an Automated Insulin Delivery System in the Management of Postprandial Glucose Levels During a Pediatric School Camp: The Control-IQ Potato Challenge 30
Daily Carbohydrate Entries and Glycemic Outcomes Following Automated Insulin Delivery System Initiation in Youth With Type 1 Diabetes: A Real-World Multinational Longitudinal Study 29
Maintaining the gluten-free diet: The key to improve glycemic metrics in youths with type 1 diabetes and celiac disease 28
Youth-Onset Type 2 Diabetes: Update on Epidemiology, Pathophysiology, Diagnosis, and Management Strategies 28
Editorial: Diabetic ketoacidosis in children and adolescents: From epidemiological data to clinical aspects 21
Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type 20
Glucometabolic control and Anti-Transglutaminase Antibodies at Celiac Disease onset in Type 1 Diabetes youth 19
Italian translation and validation of the CGM satisfaction scale questionnaire 19
Maintaining a gluten-free diet is associated with quality of life in youths with type 1 diabetes and celiac disease 18
Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children 18
Satisfaction with continuous glucose monitoring is positively correlated with time in range in children with type 1 diabetes 16
Skin Reactions in Children with Type 1 Diabetes Associated with the Use of New Diabetes Technologies-An Observational Study from a Regional Polish Pediatric Diabetes Center 16
Real-life evaluation of biologics in pediatric severe asthma using core outcome measures for severe asthma 7
The psychological impact of time in tight range in adolescents with type 1 diabetes: insights from real-life clinical practice 4
Early Detection of Pediatric Type 1 Diabetes: The Expanding Role of Screening 4
Higher post-prandial glucose excursions in youth with type 1 diabetes and celiac disease: Time to change the bolus? 2
Totale 8.153
Categoria #
all - tutte 28.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022252 0 14 3 32 4 2 8 9 11 69 14 86
2022/2023858 55 92 49 68 41 70 35 48 348 17 18 17
2023/2024312 12 31 18 36 30 58 12 36 10 24 15 30
2024/20251.722 29 57 12 155 149 104 116 242 329 124 130 275
2025/20264.793 339 250 272 249 360 943 548 595 752 305 151 29
Totale 8.153